REFACTOR CAPITAL
Refactor Capital is a seed-stage VC firm investing in bio, climate, and health. We aim to help create a happier, healthier, and more habitable world via software, technology, and the power of biology. Refactor typically leads or co-leads seed and pre-seed rounds with $1-2M checks.
REFACTOR CAPITAL
Industry:
Venture Capital
Founded:
2016-01-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Euro Amazon IPv6 Google Apps For Business COVID-19
Similar Organizations
Alloy Fund
Early stage VC firm, investing in big ideas and breakthrough discoveries
Almaz Capital
Almaz Capital is an early stage VC firm that invests in startups in the information technology sector.
Apricot Capital
Apricot Capital is a seed stage investment firm based in Boston, MA and Toronto, Canada.
Chloe Capital
Chloe Capital is a seed stage VC firm investing in women-led innovation companies across North America.
Deep Track Capital
Deep Track Capital is an investment firm focused exclusively on the life sciences industry.
Fathom Capital
Fathom Capital is an early-stage VC firm focusing on enterprise applications and IT infrastructure.
Headline
Headline is a global venture capital firm investing in winning teams across stages and geographies.
iFly.vc
iFly.vc is a seed-stage VC firm based in the Austin Area.
Lux Capital
Lux Capital is an investment firm investing in counter-conventional, early-stage science, and tech ventures.
LYFE Capital
LYFE Capital is a life science investment firm.
Primary Venture Partners
Primary Venture Partners is a seed stage VC firm focused on ecommerce and enterprise SaaS.
Venrock
Venrock is a venture capital firm investing in technology and healthcare companies.
Viva BioInnovator
Viva BioInnovator is the specialized investment and incubation arm of Viva Biotech.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-20 | YourChoice Therapeutics | Refactor Capital investment in Series A - YourChoice Therapeutics | 15 M USD |
| 2022-07-07 | FYTO | Refactor Capital investment in Series A - FYTO | 15 M USD |
| 2022-05-10 | Ness | Refactor Capital investment in Seed Round - Ness | 15.5 M USD |
| 2022-04-06 | Evernow | Refactor Capital investment in Series A - Evernow | 28.5 M USD |
| 2022-03-11 | Mori | Refactor Capital investment in Series B - Mori | 50 M USD |
| 2022-01-19 | 64x Bio | Refactor Capital investment in Series A - 64x Bio | 55 M USD |
| 2021-12-16 | Phytoform Labs | Refactor Capital investment in Seed Round - Phytoform Labs | 5.7 M USD |
| 2021-12-15 | Mythic Therapeutics | Refactor Capital investment in Series B - Mythic Therapeutics | 103 M USD |
| 2021-12-14 | Ophelia | Refactor Capital investment in Series B - Ophelia | 50 M USD |
| 2021-09-09 | Solugen | Refactor Capital investment in Series C - Solugen | 350 M USD |